Biotechnology
Healthcare
Investing News
Life Style
Market News
Your Environment
Johnson & Johnson Prepares to Commence Human Trials for Its COVID-19 Vaccine
Johnson & Johnson (NYSE: JNJ) revealed Wednesday that it will be commencing early-stage human trials for its budding coronavirus vaccine set to start in late July, sooner than the original September date. The company’s shares rose 1.3% in morning trading amidst the news. “Based on the strength of the...